IL106520A - FLUORINATED 17b-SUBSTITUTED 4-AZA-5a- ANDROSTANE- 3-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

FLUORINATED 17b-SUBSTITUTED 4-AZA-5a- ANDROSTANE- 3-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
IL106520A
IL106520A IL106520A IL10652093A IL106520A IL 106520 A IL106520 A IL 106520A IL 106520 A IL106520 A IL 106520A IL 10652093 A IL10652093 A IL 10652093A IL 106520 A IL106520 A IL 106520A
Authority
IL
Israel
Prior art keywords
hydrogen
fluorine
alkyl
androstane
aza
Prior art date
Application number
IL106520A
Other languages
English (en)
Other versions
IL106520A0 (en
Inventor
Achille Panzeri
Marcella Nesi
Enrico Di Salle
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of IL106520A0 publication Critical patent/IL106520A0/xx
Publication of IL106520A publication Critical patent/IL106520A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Glass Compositions (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL106520A 1992-07-31 1993-07-29 FLUORINATED 17b-SUBSTITUTED 4-AZA-5a- ANDROSTANE- 3-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM IL106520A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216284A GB9216284D0 (en) 1992-07-31 1992-07-31 Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives

Publications (2)

Publication Number Publication Date
IL106520A0 IL106520A0 (en) 1993-11-15
IL106520A true IL106520A (en) 1997-11-20

Family

ID=10719598

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106520A IL106520A (en) 1992-07-31 1993-07-29 FLUORINATED 17b-SUBSTITUTED 4-AZA-5a- ANDROSTANE- 3-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (28)

Country Link
US (1) US5407939A (cs)
EP (1) EP0607400B1 (cs)
JP (1) JP3325025B2 (cs)
KR (1) KR100311547B1 (cs)
CN (1) CN1041096C (cs)
AT (1) ATE159951T1 (cs)
AU (1) AU660562B2 (cs)
CA (1) CA2120343A1 (cs)
CZ (1) CZ286240B6 (cs)
DE (1) DE69315050T2 (cs)
DK (1) DK0607400T3 (cs)
ES (1) ES2110620T3 (cs)
FI (1) FI113778B (cs)
GB (1) GB9216284D0 (cs)
GR (1) GR3025546T3 (cs)
HU (2) HUT67043A (cs)
IL (1) IL106520A (cs)
MX (1) MX9304579A (cs)
MY (1) MY109633A (cs)
NO (1) NO305401B1 (cs)
NZ (1) NZ254787A (cs)
PH (1) PH29938A (cs)
PL (1) PL178591B1 (cs)
RU (1) RU2125061C1 (cs)
TW (1) TW286319B (cs)
UA (1) UA41291C2 (cs)
WO (1) WO1994003475A1 (cs)
ZA (1) ZA935481B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE203162T1 (de) * 1992-12-18 2001-08-15 Merck & Co Inc Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4- aza-5 alpha-androst-1-en-3-one
JP3253088B2 (ja) * 1993-06-24 2002-02-04 リチュテル・ゲデオン・ヴェジェーセティ・ジャール・エルテー 17β−置換−4−アザアンドロスタン誘導体の新規製造方法
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
ES2125495T3 (es) * 1993-10-21 1999-03-01 Merck & Co Inc 4-aza-androstano 16 sustituidos inhibidores de la isoenzima 5-alfa-reductasa 1.
GB9415178D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 4-azasteroids with side-chain fluoroketones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
IT1275594B1 (it) * 1995-07-21 1997-08-06 Pharmacia S P A Ora Pharmacia Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide
GB9518858D0 (en) * 1995-09-14 1995-11-15 Pharmacia Spa Phenylsubstituted 4-azasteroid fluoroderivatives
GB9727522D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Process for preparing carboxamido-4-azasteroids
US6645974B2 (en) * 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
IL163825A0 (en) * 2002-03-13 2005-12-18 Merck & Co Inc Fluorinated 4-azasteroid derivatives as androgen receptor modulators
AU2004255200A1 (en) * 2003-06-30 2005-01-20 Merck & Co., Inc. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
AU2004256075B2 (en) * 2003-06-30 2008-12-04 Merck Sharp & Dohme Corp. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
AU2004259664B2 (en) * 2003-06-30 2009-05-28 Merck Sharp & Dohme Corp. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
JP2007521292A (ja) 2003-06-30 2007-08-02 メルク エンド カムパニー インコーポレーテッド アンドロゲン受容体モジュレータとしての17−アセトアミド−4−アザステロイド誘導体
JP2007505120A (ja) * 2003-09-10 2007-03-08 メルク エンド カムパニー インコーポレーテッド アンドロゲン受容体調節因子としての17−複素環式−4−アザステロイド誘導体。
CA2537663A1 (en) 2003-09-10 2005-03-24 Merck & Co., Inc. 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
CN1942187A (zh) * 2004-04-08 2007-04-04 默克公司 作为雄激素受体调节剂的17β-乙酰胺-4-氮杂甾体化合物
US20100105700A1 (en) * 2008-10-28 2010-04-29 Lead Therapeutics, Inc. Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
KR102541494B1 (ko) 2019-09-11 2023-06-08 주식회사 엘지화학 고흡수성 수지의 제조 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
GB9002922D0 (en) * 1990-02-09 1990-04-04 Erba Carlo Spa 17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives
AUPP930799A0 (en) * 1999-03-18 1999-04-15 University Of Sydney, The Optical planar waveguide device and method of its fabrication

Also Published As

Publication number Publication date
HK1011693A1 (en) 1999-07-16
EP0607400A1 (en) 1994-07-27
JP3325025B2 (ja) 2002-09-17
NO941080D0 (no) 1994-03-24
MY109633A (en) 1997-03-31
ZA935481B (en) 1994-05-16
IL106520A0 (en) 1993-11-15
FI941424A7 (fi) 1994-05-27
HUT67043A (en) 1995-01-30
ES2110620T3 (es) 1998-02-16
CZ286240B6 (cs) 2000-02-16
CN1085224A (zh) 1994-04-13
UA41291C2 (uk) 2001-09-17
HU211238A9 (en) 1995-11-28
HU9400914D0 (en) 1994-06-28
NZ254787A (en) 1995-11-27
PL178591B1 (pl) 2000-05-31
CN1041096C (zh) 1998-12-09
NO305401B1 (no) 1999-05-25
WO1994003475A1 (en) 1994-02-17
AU660562B2 (en) 1995-06-29
ATE159951T1 (de) 1997-11-15
DE69315050D1 (de) 1997-12-11
PH29938A (en) 1996-09-16
JPH06511497A (ja) 1994-12-22
NO941080L (no) 1994-05-18
TW286319B (cs) 1996-09-21
RU2125061C1 (ru) 1999-01-20
US5407939A (en) 1995-04-18
DE69315050T2 (de) 1998-03-05
GR3025546T3 (en) 1998-03-31
CZ153893A3 (en) 1994-02-16
FI113778B (fi) 2004-06-15
GB9216284D0 (en) 1992-09-16
AU4704893A (en) 1994-03-03
KR100311547B1 (ko) 2002-06-20
CA2120343A1 (en) 1994-02-17
FI941424A0 (fi) 1994-03-28
MX9304579A (es) 1994-02-28
EP0607400B1 (en) 1997-11-05
DK0607400T3 (da) 1998-01-26

Similar Documents

Publication Publication Date Title
IL106520A (en) FLUORINATED 17b-SUBSTITUTED 4-AZA-5a- ANDROSTANE- 3-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO950849D0 (no) Derivater av valproin og 2-valproensyreamider og anvendelse som antikonvulsanter
ATE83773T1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
NO941461D0 (no) 3-deoksy-oligosakkarider, fremgangsmåter for fremstilling derav og farmasöytiske blandinger inneholdende dem
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
IE821434L (en) Arylsulphonamides.
ES8307260A1 (es) Procedimiento para la obtencion de derivados de trifluormetil-fenoxifenil-silicio.
PH24309A (en) Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)-ergolines and pharmaceutical formulations thereof
GR3029428T3 (en) Novel bisoxadiazolidine derivative
IL99244A0 (en) Penem compounds
IL75887A0 (en) Indoloindole derivatives,their preparation and pharmaceutical compositions containing them
ES8201539A1 (es) Procedimiento de preparacion de nuevas ortoarilideneaminofe-netilaminas y de sus sales de adicion con acidos farmacolo- gicamente compatibles
ES481057A1 (es) Procedimiento para preparar una composicion protectora de - plantas que comprende como antidoto un derivado de 1,4-oxa- za-spirohidrocarburo.
GR3021966T3 (en) Thiocarbamate sulfoxide composition for deterring ethanol ingestion
IL106564A (en) Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them
EP0230474A4 (en) BIS-DIOXOPIPERAZINE COMBATS AND MEDICINAL PRODUCTS THEREOF.
SG47940A1 (en) Light screening agent
GR3006223T3 (cs)
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
DE3467297D1 (en) Benzobicyclononane amino derivatives with anticonvulsive properties

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH Patent void
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees